Leveraging high-fidelity physiological waveforms to unlock AI-Driven insights in cardiac function.
Funding
Early Stage
Current Stage
$15.1M
Recent Funding
$15.1M
Total Funding
Recent News
Cardiosense names Eric Meizlish as new CEO
Seattle TechFlash
Cardiosense Names Eric Meizlish as CEO
Medical Product Outsourcing